Solara Active Pharma Sciences Limited — Updates, 28-04-2026: Press Release

Solara Pharma's Puducherry Ibuprofen plant successfully concluded its US FDA inspection with a "Voluntary Action Indicated" classification. This confirms robust cGMP compliance, reinforcing global quality standards and operational reliability for investors.